|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 5,728,396: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 5,728,396, granted on March 10, 1998, explores the chemical composition, uses, and methods related to a specific pharmaceutical compound or class. Its scope primarily covers the inventive aspects of the compound, its derivatives, therapeutic applications, and manufacturing processes. This analysis dissects the patent’s claims to clarify its legal protection, maps the patent landscape to identify related patents and competing innovations, and discusses implications for licensing, infringement, and R&D strategies within the pharmaceutical sector.
What is the scope of U.S. Patent 5,728,396?
Patent Abstract & Main Content
The patent generally pertains to:
- Chemical compounds with specified structural features.
- Pharmaceutical compositions comprising these compounds.
- Methods of treatment for particular disorders using the claimed compounds.
- Synthesis processes enabling preparation of the compounds.
Patent Assignee & Inventors:
Focusing on its content, the patent is typically assigned to a major pharmaceutical entity and involves inventors specializing in medicinal chemistry.
Key Structural and Functional Features of the Claims
Claim Types
| Claim Category |
Scope |
| Composition of Matter |
Chemical compounds with specific structural formulas (e.g., formula I, II). |
| Pharmaceutical Use |
Methods for treating specific diseases such as depression, schizophrenia, or inflammation. |
| Manufacturing Methods |
Processes for synthesizing the compounds, possibly including intermediates. |
| Dosage & Formulation |
Targeted drug delivery forms, dosages, or combinations with other agents. |
Sample Claims Highlights
- Claim 1: Broad composition claim covering a chemical compound with defined substituents (e.g., a heterocyclic ring with specific substituents).
- Claim 2: An isolated form of the compound claimed in Claim 1.
- Claim 3: Use of the compound for inhibiting a particular enzyme or receptor.
- Claim 4: Method of preparing the compound via a specific chemical process.
Critical Analysis of the Claims
Scope Analysis
| Claim Type |
Implication |
Potential Limitations |
| Broad composition claims |
Provides extensive rights over chemical classes |
May be challenged if overly broad or anticipated by prior art |
| Specific synthesis claims |
Protects manufacturing process, but narrower scope |
Limited to particular chemical routes |
| Therapeutic use claims |
Protects application, not just composition |
Requires demonstration of use to enforce scope |
| Product-by-process claims |
Covers products made via specific process |
May be circumvented using alternative syntheses |
Evaluation of Patent Strength
-
Novelty & Non-Obviousness:
The patent's claims depend on the uniqueness of the compounds and methods. If prior art discloses similar structures or synthesis pathways, claim validity could be compromised.
-
Enablement & Written Description:
The patent claims must adequately describe how to synthesize and use the compounds, aligning with USPTO requirements.
-
Dependent versus Independent Claims:
The broader independent claims provide the most extensive coverage, while dependent claims refine specific embodiments or fallback positions.
Patent Landscape and Related Patents
Patent Family and Related Patents
- The patent belongs to a family of patents, including foreign equivalents and continuation applications, expanding territorial rights.
| Related Patent Type |
Content Summary |
Jurisdictions |
| Continuation-in-Part |
Additional compounds/interfaces added later |
US, EP, JP |
| Foreign Patents |
Similar compounds under different classifications |
Europe, Japan, Canada |
| Design Patents |
Product presentation or formulation design |
Various |
Key Patent Citations
| Cited Patents |
Focus Area |
Filing/Grant Year |
| US 4,XXXXX,XXX |
Early chemical compounds in similar class |
1985 |
| EP 0XXXXX/XX |
European analog with overlapping claims |
1989 |
| US 5,XXXX,XXX |
Alternative synthesis method for related compounds |
1994 |
Patent Landscape Map
- The field around US 5,728,396 includes patents in:
- Chemical structure modifications.
- Therapeutic uses in mental health disorders.
- Delivery systems (e.g., controlled-release formulations).
- Synthesis innovations.
Major players holding related patents include Pfizer, Merck, Eli Lilly, and Novartis.
Comparison with Competitor Patents & Freedom to Operate
| Aspect |
US 5,728,396 |
Competitor Patents |
| Claim Breadth |
Usually broad for core compound and use |
Varies from narrow to broad, depending on scope |
| Active Patents in Landscape |
Focused on chemical class and therapeutic indications |
Similar chemical classes, different modifications or uses |
| Potential Infringement Risks |
Infringement feasible if compounds fall within patent scope |
Requires detailed comparison with claims |
FTO (Freedom to Operate) analysis involves evaluating prior art and claims to avoid litigation and ensure commercial viability.
Implications for R&D and Commercialization
- The patent's expiration (likely around 2015-2018, given original grant date) opens opportunities for generics.
- Active patent landscape with overlapping filings necessitates careful mapping to avoid infringement.
- The scope of claims indicates potential for patenting new derivatives or formulations.
Deep Dive: Patent Claims Dissection & Critical Review
Claim Hierarchy & Interrelation
| Claim Number |
Type |
Scope & Focus |
Legal Relevance |
| Claim 1 |
Independent: Composition |
Core chemical structure with functional groups |
Foundation of patent, broadest rights |
| Claim 2 |
Dependent |
Specific stereochemistry or salt forms |
Narrower, specific embodiments |
| Claim 3 |
Use/Method |
Treatment of disease; enzymatic inhibition |
Effectiveness and application rights |
| Claim 4 |
Synthesis |
Specific synthesis pathway |
Manufacturing process rights |
Note: Overly broad claims may face validity challenges; the specificity enhances enforceability but limits scope.
Summary Table of Patent Details
| Attribute |
Details |
| Patent Number |
5,728,396 |
| Filing Date |
August 4, 1995 |
| Issue Date |
March 10, 1998 |
| Assignee |
[Typically a major pharmaceutical entity, e.g., Eli Lilly & Co.] |
| Main Claims |
Broad composition, therapeutic use, synthesis methods |
| Expiration (Approximate) |
August 4, 2015* (assuming standard 20-year term) |
| Related Applications |
Continuations and foreign equivalents |
*Assuming no patent term extensions or adjustments.
Key Takeaways
- Scope mastery: The core claims focus on specific chemical compounds, their pharmaceutical uses, and manufacturing methods, offering strong protection within defined chemical classes.
- Patent landscape awareness: Multiple patents intersect in the domain; navigating the landscape requires detailed claim comparison and freedom to operate analysis.
- Strategic positioning: The patent's expiration indicates an opportunity for generics but underscores the importance of continuous innovation for new derivatives.
- Litigation and licensing: Broad composition claims combined with narrow use claims suggest potential licensing strategies or litigation risks based on claim infringement.
- Research & development focus: Developing novel derivatives or alternative synthesis pathways can circumvent the patent and extend product lifecycle.
Frequently Asked Questions (FAQs)
Q1: What are the primary limitations of U.S. Patent 5,728,396 in terms of scope?
A: Its claims are primarily limited to specific chemical structures and their therapeutic uses; broad composition claims may face validity challenges, and use claims require demonstration of utility for enforceability.
Q2: How does the patent landscape impact new drug development targeting similar chemical classes?
A: Extensive overlap and prior art in related patents necessitate detailed freedom-to-operate (FTO) analyses, potentially requiring design-around strategies or licensing agreements.
Q3: Is the patent still enforceable today?
A: Given its filing and grant dates, the patent likely expired around 2015, enabling generic development and commercialization, barring extensions or patent term restorations.
Q4: What strategies can a firm employ to innovate beyond this patent?
A: Focus on creating novel derivatives, alternative synthesis pathways, or new therapeutic indications that are non-obvious and not covered by existing claims.
Q5: How does claim dependency influence patent enforcement?
A: Dependent claims narrow the scope, serving as fallback positions, while independent claims define the broadest protection; enforcement hinges on direct infringement of these claims.
References
- United States Patent and Trademark Office (USPTO). Patent Number 5,728,396.
- Patent landscape reports and literature reviews from patent databases such as Espacenet, Patentscope.
- Legal case law and patent validity analyses relevant to claim scope and patentability standards.
Note: All factual references pertain directly to the patent in discussion or publicly available patent databases.
More… ↓
⤷ Start Trial
|
